Stem Cell Therapy and FDA Regulation
With stem cell therapies making headlines for everything from joint pain relief to anti-aging, it’s easy to get swept up in the excitement. But when it comes to safety, legality, and scientific backing, it’s important to understand what’s actually approved by the FDA — and what’s not.
FDA Lifts Clinical Hold on Tab-Cel, Allowing Trials to Resume for EBV+ PTLD
The FDA has lifted the clinical hold on the Tab-Cel IND application, allowing phase 2 and phase 3 trials for EBV+ PTLD to continue. This marks a crucial step in advancing treatment options for this rare post-transplant condition.
